Prot# M-INTG03-062: Early Glycoprotein IIb/IIIa Inhibition in Non-ST Segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluation the Clinical Benefits of Early Front-Loaded Eptifibatied in the Treatment of Patients w/Non-S

Project: Research project

Project Details

Effective start/end date3/16/053/1/12


  • Duke Clinical Research Institute (M-INTG03-062 // M-INTG03-062)
  • Millennium Pharmaceuticals, Inc. (M-INTG03-062 // M-INTG03-062)